60
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Neutralization of Pseudomonas aeruginosa enzymatic activity by antibodies elicited with proteins of Larrea divaricata Cav.

, , , , &
Pages 346-353 | Received 12 May 2011, Accepted 21 Jul 2011, Published online: 23 Jan 2012

References

  • Kiesling R., Flora de, San Juan. República Argentina. Volumen II. Estudio Sigma. 2003.
  • Quiroga, E.N., Sampietro, A.R., Vattuone, M.A. In vitro fungitoxic activity of Larrea divaricata cav. extracts. Lett Appl Microbiol 2004, 39, 7–12.
  • Anesini, C., Perez, C. Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol 1993, 39, 119–128.
  • Stege, P.W., Davicino, R.C., Vega, A.E., Casali, Y.A., Correa, S., Micalizzi, B. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori. Phytomedicine 2006, 13, 724–727.
  • Bongiovanni, G., Cantero, J., Eynard, A., Goleniowski, M. Organic extracts of Larrea divaricata Cav. induced apoptosis on tumoral MCF7 cells with an higher cytotoxicity than nordihydroguaiaretic acid or paclitaxel. J Exp Ther Oncol 2008, 7, 1–7.
  • Davicino, R., Manuele, M.G., Turner, S., Ferraro, G., Anesini, C. Antiproliferative activity of Larrea divaricata Cav. on lymphoma cell line: participation of hydrogen peroxide in its action. Cancer Invest 2010, 28, 13–22.
  • Anesini, C., Genaro, A., Cremaschi, G., Zubillaga, M., Boccio, J., Sterin-Borda, L., Borda, E. “In vivo” and “in vitro” antitumoral action of Larrea divaricata Cav. Acta Physiol Pharmacol Ther Latinoam 1996, 46, 33–40.
  • Davicino, R., Mattar, A., Casali, Y., Porporatto, C., Correa, S., Micalizzi, B. Activation and apoptosis of mouse peritoneal macrophages by extracts of Larrea divaricata Cav. (jarilla). Int Immunopharmacol 2006, 6, 2047–2056.
  • Davicino, R., Mattar, A., Casali, Y., Porporatto, C., Correa, S.G., Micalizzi, B. In vivo immunomodulatory effects of aqueous extracts of Larrea divaricata Cav. Immunopharmacol Immunotoxicol 2007, 29, 351–366.
  • Mattar de Anaya, M.A., Davicino, R., Casali, Y., Correa, S., Micalizzi, B. Cross-reaction between proteins of Larrea divaricata Cav. (jarilla) and proteins of Gram-negative bacteria. Immunopharmacol Immunotoxicol. 2009, 31, 654–660.
  • Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265–275.
  • Daza, N., Moronta, R., O’Daly, J. Variabilidad en los exoproductos de Pseudomonas aeruginosa aislada de diferentes muestras clínicas. VITAE Academia Biomédica Digital, 2006, 27.
  • Hancock, R., Woodruff, W. Roles of porin and b-lactamase in intrinsic antibiotic resistance of Pseudomonas aeruginosa. Rev Infect Dis 1988, 10, 770–775.
  • George, R.H. Pseudomonas infection in cystic fibrosis. Arch Dis Child 1987, 62, 438–439.
  • Coin, D., Louis, D., Bernillon, J., Guinand, M., Wallach, J. LasA, alkaline protease and elastase in clinical strains of Pseudomonas aeruginosa: Quantification by immunochemical methods. FEMS Immunol Med Microbiol 1997, 18, 175–184.
  • Govan, J.R., Deretic, V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996, 60, 539–574.
  • Twining, S.S., Kirschner, S.E., Mahnke, L.A., Frank, D.W. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci 1993, 34, 2699–2712.
  • Shilpa, K., Vinayak, K., Chakrabarty, A. Cellular function of elastasa in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol Microbiol 1998, 30, 933–041.
  • Döring, G., Pier, G.B. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 2008, 26, 1011–1024.
  • Mattar, M.A. Clostridum chauvoei: Estudio genético e inmunológico de cepas regionales para el mejoramiento de vacunas. Tesis Doctoral Universidad Nacional de San Luis. Argentina. 2001.
  • Michiels, T., Wattiau, P., Brasseur, R., Ruysschaert, J.M., Cornelis, G. Secretion of Yop proteins by Yersiniae. Infect Immun 1990, 58, 2840–2849.
  • Stanislavsky, E.S., Lam, J.S. Pseudomonas aeruginosa antigens as potential vaccines. FEMS Microbiol Rev 1997, 21, 243–277.
  • www.drlera.com/bacterial_diseases/pseudomonas_aeruginosa
  • www.textbookofbacteriology.net/proteintoxins
  • Yokota, S., Ohtsuka, H., Noguchi, H. Monoclonal antibodies against Pseudomonas aeruginosa elastase: A neutralizing antibody which recognizes a conformational epitope related to an active site of elastase. Eur J Biochem 1992, 206, 587–593.
  • Schmidttchen, A., Wolff, H., Hansson, C. Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg llcers. Acta Derm Venereol 2001, 81, 06–409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.